Contents Vol. 224, 2012
Hye Ran Park, P.H. Itin, Brigitte Dréno(Nantes Université), N. Bibas, Vasiliki Nikolaou(European Organisation for Research and Treatment of Cancer), Haleh Bagheri(Université Fédérale de Toulouse Midi-Pyrénées), Jaime Matarredona, C. Pecquet(Ludwig Cancer Research), Javier Sánchez de Vicente, J.P. Devesa, Hee Kyung Kim, J.S. Kern, Alexios S Strimpakos, E. Amsler(Sorbonne Université), Céline Vallet, Ghislaine Labetoulle, J.C. Escribano-Stablé, Andreas Katsambas(Hygeia Hospital), Annamaria Cuffini(University of Turin), Marco Ardigò(San Gallicano Hospital), A. Jaén, Yuichi Teraki(Social Insurance Saitama Chuo Hospital), A. Maza, Nadia Chouini–Lalanne, L. Peuvrel(Institut de Cancérologie de l'Ouest), M. Saint‐Jean, O. Bayrou, Seiichi Izaki, V. Sartor, C. Doménech, Young Lip Park, Soo-Bin Im(Pusan National University Hospital), Catherine Le Fol, C. Paul(Université Fédérale de Toulouse Midi-Pyrénées), G. Quéreux(Nantes Université), J. Nougué, R. Boeni, Yoshihiro Sato, Andreas Arnold(University Hospital of Basel), Christina Antoniou(Peter MacCallum Cancer Centre), A. Brocard, Katsuhiro Hitomi, Kostas Syrigos, Alexander Stratigos(National and Kapodistrian University of Athens), Dong Seong Shin, F. Giordano‐Labadie(Université Toulouse III - Paul Sabatier), C. Francès, M.C. Marguery, C. Bulaï Livideanu(Université Fédérale de Toulouse Midi-Pyrénées)
Cited by 0
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k